The industrial recombinant protein is a controlled form of protein, which is created in many ways to produce proteins in larger quantities. It is also being used at large in the modification of gene and in many useful commercial products as these proteins take a very short time to develop as compared to other types. The process involved in the formation of an industrial recombinant protein is called recombinant technology. The industrial recombinant protein market is gaining a lot of demand and attention across the world as industrial recombinant proteins and its products have diverse applications in the industries such as food, pesticides, pharmaceutical, veterinary, agriculture and detergents. Manufacturers of industrial recombinant protein have great opportunities for business in these sectors. The countries like the US, Mexico, Canada France, Italy, and many others who spend a lot of money on research are playing a key role in driving the industrial recombinant protein market. Some of the companies that are leading industrial recombinant protein market are Eli Lilly and Company, Abnova Corporation, Biologics International Corp, and Genemed Biotechnologies, Inc.
Increased Demand in Industrial Recombinant Protein Market
Over the years, industrial recombinant protein has gained a lot of attention. The key driver of industrial recombinant protein market is the increase in the expenditure on research & development and the increased use and applications of industrial recombinant protein in pharmaceutical, agriculture and food industries. There is a hike in chronic diseases amongst people across the world which has led to growth in the industrial recombinant protein market as these proteins are essential in curing the chronic illness. Many economies are inclining towards biotechnology across the world which is also one of the drivers of the industrial recombinant protein market. The main restraint of industrial recombinant protein is that the production process requires excessive cost and time, but researchers and existing manufacturers are continuously working towards more affordable and less time-consuming options.
Global Industrial Recombinant Protein Market: Market Segmentation
Industrial recombinant protein market segmentation on the basis of the end user:
Industrial recombinant protein market segmentation on the basis of the application:
- Basic Research & Development
- Drug discovery
Industrial recombinant protein market segmentation on the basis of the type:
- 14-3-3 beta recombinant protein
- 14-3-3 protein epsilon recombinant protein
- 15-PGDH recombinant protein
- Others (17-beta HSD 10 recombinant protein, 2 hydroxyacyl CoA lyase 1 recombinant protein, 41BB receptor recombinant protein)
Global Industrial Recombinant Protein Market: Key Players
Some of the leading players in the industrial recombinant protein market are Prospec-Tany Technogene Ltd., Novo Nordisk A/S, Novoprotein, Merck KGaA, Kaneka Corporation, Enzo Life Sciences, Inc., Eli Lilly and Company, Abnova Corporation, Biologics International Corp, and, Genemed Biotechnologies, Inc. Novo Nordisk A/S is currently looking for partners so as to innovate together in this area and develop and expand their research.
Opportunities for Market Participants
The countries like the US, China, Canada, and France are spending a huge amount of money on research & development of industrial recombinant Protein to find innovative ways for reducing the cost and time in the production of industrial recombinant proteins. Looking at the positive impact of industrial recombinant protein on chronic diseases, the usage of the industrial recombinant protein is increasing exponentially in food and drugs. This is where industrial recombinant proteins have a huge market to cater to. Manufacturers have a lot of opportunities in underdeveloped and developing countries where there are fewer resources available for the pharmaceutical, and food industries to get the industrial recombinant protein. Industrial recombinant proteins are also being used in the agriculture industry which is the primary source of income to the Asian and South African countries. This gives market entrants and existing players a huge platform to enter into industrial recombinant protein market. In addition to this, here is an upsurge in the drug discovery due to more need of medicines across the globe, which is taking the industrial recombinant protein market to a different level. Manufacturers even have good opportunities in detergent making companies as these companies also use industrial recombinant proteins for getting better results.
The industrial recombinant protein market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the citrus distillate market, including but not limited to: type, application and end user.
The study is a source of reliable data on:
- Industrial recombinant protein market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The industrial recombinant protein market report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the industrial recombinant protein market report projects the attractiveness of each major segment over the forecast period.
Highlights of the industrial recombinant protein market report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the industrial recombinant protein Market
- Recommendations to companies for strengthening their foothold in the industrial recombinant protein market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.